Europe Lung Cancer Diagnostics Market Size & Outlook

The lung cancer diagnostics market in Europe is expected to reach a projected revenue of US$ 6,289.9 million by 2033. A compound annual growth rate of 6.4% is expected of Europe lung cancer diagnostics market from 2025 to 2033.
Revenue, 2024 (US$M)
$3,567.1
Forecast, 2033 (US$M)
$6,289.9
CAGR, 2025 - 2033
6.4%
Report Coverage
Europe

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Europe lung cancer diagnostics market, 2021-2033 (US$M)

To keep accessing Horizon, please sign in or register for a free account

  • Access to global market statistics
  • Access to company profiles
  • Free use-cases & research insights

No credit card required*

Europe lung cancer diagnostics market highlights

  • The Europe lung cancer diagnostics market generated a revenue of USD 3,567.1 million in 2024.
  • The market is expected to grow at a CAGR of 6.4% from 2025 to 2033.
  • In terms of segment, non-small cell lung cancer (nsclc) was the largest revenue generating type in 2024.
  • Non-small cell lung cancer (NSCLC) is the most lucrative type segment registering the fastest growth during the forecast period.
  • Country-wise, Germany is expected to register the highest CAGR from 2025 to 2033.


Europe data book summary

Market revenue in 2024USD 3,567.1 million
Market revenue in 2033USD 6,289.9 million
Growth rate6.4% (CAGR from 2025 to 2033)
Largest segmentNon-small cell lung cancer (nsclc)
Fastest growing segmentNon-small cell lung cancer (NSCLC)
Historical data covered2021 - 2023
Base year for estimation2024
Forecast period covered2025 - 2033
Quantitative unitsRevenue in USD million
Market segmentationSmall cell lung cancer (SCLC), Non-small cell lung cancer (NSCLC)


Other key industry trends

  • In terms of revenue, Europe region accounted for 28.8% of the global lung cancer diagnostics market in 2024.
  • Globally, North America is projected to lead the regional market in terms of revenue in 2033.
  • Asia Pacific is the fastest growing regional market and is projected to reach USD 5,776.2 million by 2033.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Lung Cancer Diagnostics Market Companies

Name Profile # Employees HQ Website
NeoGenomics Inc View profile 2100 9490 NeoGenomics Way, Fort Myers, FL, United States, 33912 https://www.neogenomics.com
Myriad Genetics Inc View profile 2700 320 Wakara Way, Salt Lake City, UT, United States, 84108 https://www.myriad.com
Qiagen NV View profile 5900 Hulsterweg 82, Venlo, LI, Netherlands, 5912 PL https://www.qiagen.com
Bio-Rad Laboratories Inc View profile 8030 1000 Alfred Nobel Drive, Hercules, CA, United States, 94547 https://www.bio-rad.com
Agilent Technologies Inc View profile 17700 5301 Stevens Creek Boulevard, Santa Clara, CA, United States, 95051 https://www.agilent.com
Illumina Inc View profile 9300 5200 Illumina Way, San Diego, CA, United States, 92122 https://www.illumina.com
Roche Holding AG View profile 103605 Grenzacherstrasse 124, Basel, Switzerland, 4070 https://www.roche.com
Thermo Fisher Scientific Inc View profile 122000 168 Third Avenue, Waltham, MA, United States, 02451 https://www.thermofisher.com
BioMerieux SA View profile 13982 Marcy l’Etoile, Lyon, France, 69280 http://www.biomerieux.com
Abbott Laboratories View profile 114000 100 Abbott Park Road, Abbott Park, IL, United States, 60064-6400 https://www.abbottinvestor.com

Europe lung cancer diagnostics market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to lung cancer diagnostics market will help companies and investors design strategic landscapes.


Non-small cell lung cancer (nsclc) was the largest segment with a revenue share of 73.45% in 2024. Horizon Databook has segmented the Europe lung cancer diagnostics market based on small cell lung cancer (sclc), non-small cell lung cancer (nsclc) covering the revenue growth of each sub-segment from 2021 to 2033.


Reasons to subscribe to Europe lung cancer diagnostics market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of Europe lung cancer diagnostics market databook

  • Our clientele includes a mix of lung cancer diagnostics market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of continent-level data and insights on the Europe lung cancer diagnostics market , including forecasts for subscribers. This continent databook contains high-level insights into Europe lung cancer diagnostics market from 2021 to 2033, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

Europe lung cancer diagnostics market size, by country, 2021-2033 (US$M)

Europe Lung Cancer Diagnostics Market Outlook Share, 2024 & 2033 (US$M)

Europe lung cancer diagnostics market size, by country, 2021-2033 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more
Chat with us
Research Assistance
Online